ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2020年07月28日 10時00分
Source:
Eisai
エーザイ・DeNA 業務提携契約に基づきスマートフォンアプリ「Easiit(イージット)アプリ」を共同提供
エーザイの認知症プラットフォームEasiitが本格始動
東京, 2020年07月28日 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役 CEO:内藤 晴夫、以下 エーザイ)と株式会社ディー・エヌ・エーの子会社である DeSC ヘルスケア株式会社(本社:東京都、代表取締役社長:瀬川 翔、代表取締役医師:三宅 邦明、以下 ディー・エヌ・エーグループを総称してDeNA)は、エーザイが構築を進めている認知症領域のデジタル・プラットフォームについて、その基盤となるアプリの共同開発および認知症領域の課題解決・支援を目指す業務提携契約に基づき、認知症に備えるためのブレインパフォーマンスアプリ「Easiit(イージット)」(以下「Easiit アプリ」)の提供を 2020 年 7 月 28 日(火)に開始したことをお知らせします。本アプリの提供開始により、エーザイ認知症プラットフォーム Easiit が本格始動しました。
認知症領域で 35 年以上にわたる創薬及び事業活動の経験を有するエーザイと、ゲームやスポーツのノウハウを活用し「楽しみながら、健康に。」をテーマに、ヘルスケアサービスの提供・行動変容の実績を有する DeNA の両社は、共同開発した「Easiit アプリ」で脳と体の健康データを可視化し、ブレインパフォーマンスの維持サポートや生活に役立つ情報提供などを通じた生活者の皆様のより良い健康習慣への貢献をめざします。両社は「Easiit アプリ」の機能拡張などを含め、デジタル・プラットフォームにおける連携を引き続き進めてまいります。
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2020/news202047.html
概要:エーザイ株式会社
詳細は www.eisai.co.jp をご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Fujitsu's AI-powered supply chain solution selected as transformative example of applied-AI technology by World Economic Forum
Jul 14, 2025 10:30 JST
"URECE" (Dotinurad) Launched in China as a treatment for Gout
Jul 14, 2025 10:20 JST
Mitsubishi Motors Added to FTSE4Good Index Series, FTSE Blossom Japan Index and FTSE Blossom Japan Sector Relative Index for Consecutive Years
Jul 11, 2025 16:28 JST
All-New MAZDA CX-5 Debuts in Europe
Jul 10, 2025 18:56 JST
Sharp Signs Official Partnership with Tottenham Hotspur FC Pre-season Tour 2025 with Its AQUOS Brand
Jul 10, 2025 17:30 JST
Hitachi develops "Metaverse Platform for Nuclear Power Plants" to enhance efficiency in construction and maintenance operations
Jul 09, 2025 19:02 JST
"Development of Integrated Simulation Platform for Sustainable and Competitive Maritime Industry" has been selected as a R&D project under K Program
Jul 08, 2025 20:30 JST
Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment
Jul 08, 2025 09:31 JST
MHI Awarded Contract for Basic Design of Japan's Largest CO2 Capture Plant at Hokkaido Electric Power's Tomato-Atsuma Power Station
Jul 07, 2025 11:15 JST
Fujitsu's high-precision skeleton recognition AI adopted to enhance figure skating athlete training
Jul 05, 2025 13:40 JST
DENSO Acquires Axia Vegetable Seeds to Realize Sustainable Agriculture
Jul 04, 2025 16:20 JST
MHIET Launches 450kW Gas Cogeneration System Capable of Hydrogen Co-Firing
Jul 04, 2025 15:13 JST
Yachiyo Engineering and NEC launch adaptation finance study in Indonesia to calculate the adaptation value of disaster prevention measures
Jul 04, 2025 13:25 JST
Fujitsu to implement store monitoring solution for METRO Inc. in Canada, enhancing operational efficiency and policy compliance
Jul 04, 2025 13:19 JST
Fujitsu to develop ETF trading platform based on TSE's CONNEQTOR and provide it to Australian Securities Exchange
Jul 03, 2025 11:14 JST
Mitsubishi Motors Launches the All-New Grandis for the European Market
Jul 02, 2025 12:10 JST
Valuufy partners with Mainichi Future Creation Lab, Supporting New Approaches to Business Sustainability
Jul 02, 2025 12:00 JST
Fujitsu launches solution to enhance customers' global supply chain resilience
Jul 02, 2025 11:32 JST
MHI Receives Order to Supply Four Circulating Water Pumps for Units 5 and 6 of Sanmen Nuclear Power Plant in China Under Collaboration with Dongfang Electric Machinery
Jul 02, 2025 11:30 JST
Multi-purpose Arena in Odaiba Aomi Area TOYOTA ARENA TOKYO Construction Completed
Jul 01, 2025 22:56 JST
More Latest Release >>
Related Release
"URECE" (Dotinurad) Launched in China as a treatment for Gout
7/14/2025 10:20:00 AM JST
Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment
7/8/2025 9:31:00 AM JST
Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan
6/2/2025 5:46:00 PM JST
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China
5/28/2025 5:45:00 PM JST
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025
5/21/2025 3:00:00 PM JST
Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro
5/16/2025 5:21:00 PM JST
Eisai Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star
4/30/2025 2:17:00 PM JST
Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union
4/18/2025 4:52:00 PM JST
Eisai to Divest Rights for Pariet in China to Peak Pharma
4/1/2025 1:15:00 PM JST
World's First Early Alzheimer's Disease Treatment Developed in Japan LEQEMBI Receives Prime Minister's Award at the 12th Technology Management and Innovation Awards
3/25/2025 5:28:00 PM JST
More Press release >>